ИНГИБИТОРЫ МОНОАМИНООКСИДАЗЫ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ

摘要

The invention relates to the chemical and pharmaceutical industry and to medicine, in particular, to medicinal agents based on a mixture of natural oligomers of isoprenol (Ropren), which inhibits monoamine oxidase (MAO) activity; and to a method for treatment of patients suffering from diseases associated with the excessive activity of monoamine oxidase. The given invention consists of the development of a new therapeutic substance with minimal side effects that is currently a topical issue for treatment of the corresponding diseases. The proposed:
- Therapeutic substance consisted of polyprenols of formula (1) for treatment of patients with diseases associated with excessive activity of monoamine oxidase.
where n = 8-20. with content of polyprenols of formula (1) in the given therapeutic substance from 0.1 to 80%.
- The treatment method of diseases associated with excessive activity of monoamine oxidase, which consists of administration to the patients of a single or multiple doses of polyprenols of formula (1) in the amount of 1 to 150 mg per day, in the form of an individual agent or as a pharmaceutical composition including excipients.